PKC 412 small-molecule tyrosine kinase inhibitor: ...[Cancer. 2007] - PubMed Result

NCBI / PubMed A service of the U.S. National Library of Medicine and the National Institutes of Health / My NCBI ... BACKGROUND: PKC412 is a kinase inhibitor that blocks protein kinase C (PKC), vascular endothelial growth factor...
http://www.ncbi.nlm.nih.gov/pubmed/17676584/

 

PKC 412 small-molecule tyrosine kinase inhibitor: single-compound therapy for pancreatic cancer.

Home / Pharmaceutical Reports / Pharmaceutical report sourcer / DailyUpdates: Advances for Drug Development / Key Scientific Journal Articles ... : PKC412 is a kinase inhibitor that blocks protein kinase C (PKC), vascular endothelial growth factor...
http://www.leaddiscovery.co.uk/articles/17676584/

 

Oral Cancer: Free Medical and Health Information on Oral Cancer Research and Treatment

HOME ABOUT US CONTACT ADVERTISE WITH US / The Oral Cancer File / C E N T E R F O R C U R R E N T R E S E A R C H / Approved by / Physicians' / Home Page / Medinex / Seal of Approval ... Motesanib diphosphate (AMG 706) is a novel oral inhibitor of...
http://www.lifestages.com/health/oralcanc.html

 

Dictionary Contents: R

... r; R17 bacteriophage; Ra; raash; Rab28 GTPase; Rab29 GTPase; rabate; rabbeting; rabbinism; rabbit; rabbit fever; rabbit fibroma; rabbit fibroma virus; rabbit haemorrhagic disease; rabbit myxoma virus; rabbit plague; rabbitpox; rabbitpox virus;...
http://cancerweb.ncl.ac.uk/omd/contents/R.html

 

Sunitinib (Sutent) Effective in Renal, Gastrointestinal, and Neuroendocrine Cancers: Presented at ICACTSunitinib (Sutent) Effective in Renal, Gastrointestinal,

... Sunitinib is an oral highly selective, multi-targeted tyrosine kinase inhibitor with antiangiogenic and antitumor activities that selectively inhibits vascular endothelial growth factor receptors, platelet-derived growth...
http://www.pslgroup.com/dg/25758a.htm